Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP982522priorityCriticalpatent/ECSP982522A/en
Publication of ECSP982522ApublicationCriticalpatent/ECSP982522A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La invención se refiere a las nuevas modificaciones B y C del compuesto 1-2(2,6-difluorbencil)-1H-1,2,3,-triazol-4-carboxamida de la fórmula (gráfico), su empleo, así como preparados farmacéuticos que contienen esta modificación a cristal.The invention relates to the new modifications B and C of compound 1-2 (2,6-difluorbenzyl) -1H-1,2,3, -triazol-4-carboxamide of the formula (graph), their use, as well as Pharmaceutical preparations containing this crystal modification.
ECSP9825221998-06-051998-06-05
GLASS MODIFICATION OF AN ACTIVE MEDICINAL SUBSTANCE (II)
ECSP982522A
(en)
TRICYCLIC UREA COMPOUNDS USEFUL FOR THE INHIBITION OF THE FUNCTION OF PROTEIN G AND FOR THE TREATMENT OF PROTEOLYTIC DISEASES, PHARMACEUTICAL COMPOSITION, AND THE USE OF THE SAME FOR THE PREPARATION OF MEDICINES.
PIRROLOPYROLONE COMPOUNDS, A PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM, ITS USE IN THE MANUFACTURE OF A MEDICINAL PRODUCT AND IN THERAPY, PROCESSES FOR ITS PREPARATION AND INTERMEDIARY COMPOUNDS FOR SUCH PROCESSES.
DERIVATIVES OF BENCIMIDAZOL 1-ARIL-2-N, S OR O-SUBSTITUTES, ITS USE FOR THE OBTAINING OF PHARMACEUTICAL DRUGS AND PREPARATIONS CONTAINING THESE DERIVATIVES